Loss of L-PHA-, PNA-, or ConA-reactive oligosaccharides is associated with a poor prognosis in human Burkitt's lymphoma

Oncology Reports

Volumn 17, Issue 4, 2007, Pages 775-779

  Suzuki, Osamu ^a   Nozawa, Yoshihiro ^a   Abe, Masafumi ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Burkitt's lymphoma; Oligosaccharides; Prognosis

Indexed keywords

ALPHA 1,6 MANNOSYLGLYCOPROTEIN BETA 1,6 N ACETYLGLUCOSAMINYLTRANSFERASE; ALPHA-1,6-MANNOSYLGLYCOPROTEIN BETA 1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE; CONCANAVALIN A; N ACETYLGLUCOSAMINYLTRANSFERASE; OLIGOSACCHARIDE; PEANUT AGGLUTININ; PHYTOHEMAGGLUTININ; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BURKITT LYMPHOMA; CHEMISTRY; CHILD; HUMAN; IMMUNOHISTOCHEMISTRY; ISOLATION AND PURIFICATION; MORTALITY; PRESCHOOL CHILD; PROGNOSIS;

ADOLESCENT; ADULT; BURKITT LYMPHOMA; CHILD; CHILD, PRESCHOOL; CONCANAVALIN A; HUMANS; IMMUNOHISTOCHEMISTRY; N-ACETYLGLUCOSAMINYLTRANSFERASES; OLIGOSACCHARIDES; PEANUT AGGLUTININ; PHYTOHEMAGGLUTININS; PROGNOSIS;

EID: 34249931854     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.4.775     Document Type: Article

References (32)

1. Dennis JW, Laferte S, Waghorne C, Breitman ML and Kerbel RS: Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science 236: 582-585, 1987. (Pubitemid 17069927)
2. Pierce M, Buckhaults P, Chen L and Fregien N: Regulation of N-acetylglucosaminyltransferase V and Asn-linked oligosaccharide β(1,6)branching by a growth factor signaling pathway and effects on cell adhesion and metastatic potential. Glycoconj J 14: 623-630, 1997. (Pubitemid 27353206)
3. Shao DM, Wang QH, Chen C, Shen ZH, Yao M, Zhou XD, Tang ZY and Gu JX: N-acetylglucosaminyltransferase V activity in metastatic models of human hepatocellular carcinoma in nude mice. J Exp Clin Cancer Res 18: 331-335, 1999.
4. Guo Hua-Bei, Zhang QS and Chen H: Effects of H-ras and v-sis overexpression on N-acetylglucosaminyltransferase V and metastasis-related phenotypes in human hepatocarcinoma cells. J Cancer Res Clin Oncol 126: 263-270, 2000.
5. Kang R, Saito H, Ihara Y, Miyoshi E, Koyama N, Sheng Y and Taniguchi N: Transcriptional regulation of the N-acetylgluco-saminyltransferase V gene in human bile duct carcinoma cells (HuCC-T1) is mediated by Ets-1. J Biol Chem 271: 26706-26712, 1996. (Pubitemid 26359077)
6. Ko JH, Miyoshi E, Noda K, Ekuni A, Kang R, Ikeda Y and Taniguchi N: Regulation of the GnT-V promoter by transcription factor Ets-1 in various cancer cell lines. J Biol Chem 274: 22941-22948, 1999.
7. Miyoshi E, Nishikawa A, Ihara Y, Gu J, Sugiyama T, Hayashi N, Fusamoto H, Kamada T and Taniguchi N: N-acetylgluco-saminyltransferase III and V messenger RNA levels in LEC rats during hepatocarcinogenesis. Cancer Res 53: 3899-3902, 1993. (Pubitemid 23267685)
8. Murata K, Miyoshi E, Kameyama M, Ishikawa O, Kabuto T, Sasaki Y, Hiratsuka M, Ohigashi H, Ishiguro S, Ito S, Honda H, Takemura F, Taniguchi N and Imaoka S: Expression of N-acetylgluco-saminyltransferase V in colorectal cancer correlates with metastasis and poor prognosis. Clin Cancer Res 6: 1772-1777, 2000. (Pubitemid 30305070)
9. Fernandes B, Sagman M, Auger M, Demetrio M and Dennis JW: β1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. Cancer Res 51: 718-723, 1991.
10. Yao M, Zhou DP, Jiang SM, Wang QH, Zhou XD, Tang ZY and Gu JX: Elevated activity of N-acetylglucosaminyltransferase V in human hepatocellular carcinoma. J Cancer Res Clin Oncol 124: 27-30, 1998. (Pubitemid 28129111)
11. Nan BC, Shao DM, Chen HL, Huang Y, Gu JX, Zhang YB and Wu ZG: Alteration of N-acetylglucosaminyltransferases in pancreatic carcinoma. Glycoconj J 15: 1033-1037, 1998. (Pubitemid 29129202)
12. Mingzhe Z, Fang H and Hakomori S: Functional role of N-glycosylation in α5β1 integrin receptor de-N-glycosylation induces dissociation or altered association of α5 and β1 subunits and concomitant loss of fibronectin binding activity. J Biol Chem 269: 12325-12331, 1994.
13. Jasiulionis MG, Chammas R, Ventura AM, Travassos LR and Brentani RR: α6β1-integrin, a major cell surface carrier of β1,6-branched oligosaccharides, mediates migration of EJ-rastransformed fibroblasts on Laminin-1 independently of its glycosylation state. Cancer Res 56: 1682-1689, 1996.
14. Yamamoto H, Swoger J, Greene S, Saito T, Hurh J, Sweely C, Leestma J, Mkrdichian E, Cerullo L, Nishikawa A, Ihara Y, Taniguchi N and Moskal JR: β1,6-N-acetylglucosamine-bearing N-glycans in human gliomas: implications for a role in regulating invasivity. Cancer Res 60: 134-142, 2000. (Pubitemid 30058743)
15. Demetriou M, Granovsky M, Quaggin S and Dennis JW: Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 409: 733-739, 2001. (Pubitemid 32144520)
16. Chui D, Sellakumar G, Green R, Sutton-Smith M, McQuistan T, Marek K, Morris H, Dell A and Marth J: Genetic remodeling of protein glycosylation in vivo induces autoimmune disease. Proc Natl Acad Sci USA 98: 1142-1147, 2001. (Pubitemid 32121200)
17. Zheng M, Fang H and Hakomori S: Functional role of N-glycosylation in α5β1 integrin receptor. J Biol Chem 269: 12325-12331, 1994.
18. Suzuki O, Nozawa Y, Kawaguchi T and Abe M: Phaseolus vulgaris leukoagglutinationg lectin-binding reactivity in human diffuse large B cell lymphoma and its relevance to the patient's clinical outcome: lectin histochemistry and lectin blot analysis. Pathol Int 49: 874-880, 1999.
19. Suzuki O, Nozawa Y, Kawaguchi T and Abe M: Alpha-2,6-sialylation of L-PHA reactive oligosaccharides and expression of N-acetylglucosaminyltransferase V in human diffuse large B cell lymphoma. Oncol Rep 10: 1759-1764, 2003.
20. Akita DH, Miyoshi E, Suzuki O, Itoh T, Katoh H and Taniguchi N: Expression of N-acetylglucosaminyltransferase V is associated with prognosis and histology in non-small cell lung cancers. Clin Cancer Res 10: 1773-1779, 2004. (Pubitemid 38443329)
21. Jaffe ES, Harris NL, Stein H and Vardiman JW: Tumors of hematopoietic and lymphoid tissues. World Health Organization Classification of Tumors. IARC press, 2001.
22. Rebbaa A, Yamamoto H, Moskal JR and Bremer EG: Binding of erythroagglutinating phytohemagglutinin lectin from Phaseolus vulgaris to the epidermal growth factor receptor inhibits receptor function in the human glioma cell line, U373 MG. J Neurochem 67: 2265-2272, 1996. (Pubitemid 26392495)
23. Sasai K, Ikeda Y, Fujii T, Tsuda T and Taniguchi N: UDP-GlcNAc concentration is an important factor in the biosynthesis of beta1,6-branched oligosaccharides: regulation based on the kinetic properties of N-acetylglucosaminyltransferase V. Glycobiology 12: 119-127, 2002. (Pubitemid 34428935)
24. Hubbard SC and Ivatt RJ: Synthesis and processing of asparagines-linked oligosaccharides. Ann Rev Biochem 50: 555-583, 1981.
25. Suzuki O, Nozawa Y and Abe M: Altered N-glycosylation in CD45 and regulatory roles of altered N-glycosylation in galectin-1-induced growth inhibition in human diffuse large B cell lymphoma. Oncol Rep 13: 109-114, 2004.
26. Suzuki O, Nozawa Y and Abe M: Regulatory roles of altered N- and O-glycosylation of CD45 in galectin-1-induced cell death in human diffuse large B cell lymphoma. Int J Oncol 26: 1063-1068, 2005.
27. Perillo NL, Pace KE, Seilhamer JJ and Baum LG: Apoptosis of T cells mediated by galectin-1. Nature 378: 736-739, 1995. (Pubitemid 126647279)
28. Monostori E, Hartyani Z, Hegedus Z, Ocsovszky I, Pallinger E and Ando I: Microheterogeneity of the cell surface tyrosine phosphatase, CD45RA, on T cells: phytohemagglutinin binding and non-binding fraction of the 220 kDa isoform. Immunol Lett 59: 171-176, 1997. (Pubitemid 27519692)
29. Guo HB, Lee I, Kamar M, Akiyama SK and Pierce M: Aberrant N-glycosylation of beta1 integrin causes reduced alpha5beta1 integrin clustering and stimulates cell migration. Cancer Res 62: 6837-6845, 2002. (Pubitemid 35424070)
30. Zhang Y, Zhao JH, Zhang XY, Guo HB, Liu F and Chen HL: Relations of the type and branch of surface N-glycans to cell adhesion, migration and integrin expressions. Mol Cell Biochem 260: 137-146, 2004. (Pubitemid 39127581)
31. + T cells results from de novo synthesis of CD45 glycans. J Biol Chem 279: 36689-36697, 2004.
32. Zheng Xu and Arther W: Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms. Nat Immun 3: 764-771, 2002.